Florencia Segal
Directeur/Membre du Conseil chez Antiva Biosciences, Inc.
Postes actifs de Florencia Segal
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
MPM BioImpact, Inc
 MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Private Equity Investor | 01/11/2022 | - |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Directeur/Membre du Conseil | 01/04/2023 | - |
Historique de carrière de Florencia Segal
Formation de Florencia Segal
| Central University of Venezuela | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
| Vénézuela | 2 |
Opérationnelle
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
| Doctorate Degree | 1 |
Sectorielle
| Finance | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
MPM BioImpact, Inc
MPM BioImpact, Inc Investment ManagersFinance MPM Bioimpact Inc (MPM Capital) is a venture capital firm founded in 1996 by Ansbert K. Gadicke and Luke B. Evnin. The firm is headquartered in Boston, Massachusetts. | Finance |
Antiva Biosciences, Inc.
Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Health Technology |
- Bourse
- Insiders
- Florencia Segal
- Expérience
